Search Within

Hematologic Malignancies Research

  1. "Journal of Nuclear Medicine"
Formats
  1. Meeting Abstract (25)
  2. Journal Article (24)
Groups
  1. Center for Hematologic Malignancies (49)
  2. GSK Faculty (49)
  3. Sloan Kettering Institute Faculty (48)
  4. Molecular Pharmacology and Chemistry Program Faculty (45)
  5. Department of Medicine (44)
  6. Hematologic Malignancies, Division of (43)

More Groups

People
  1. David Scheinberg (36)
  2. Michael Mcdevitt (23)
  3. Steven Larson (20)
  4. George Sgouros (17)
  5. Ronald Finn (15)
  6. Joseph Jurcic (8)

More People

Years
  1. 2021 (1)
  2. 2019 (1)
  3. 2018 (1)
  4. 2017 (1)
  5. 2016 (2)
  6. 2015 (1)

More Years

Publications
  1. Journal of Nuclear Medicine (49)
Publishers
  1. Society of Nuclear Medicine (49)

Results (49)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • γ-tocotrienol-loaded liposomes for radioprotection from hematopoietic side effects caused by radiotherapeutic drugs
    Journal Article

    Lee, S. G.; Kalidindi, T. M.; Lou, H.; Gangangari, K.; Punzalan, B.; Bitton, A.; Lee, C. J.; Vargas, H. A.; Park, S.; Bodei, L.; more...
    Journal of Nuclear Medicine (2021)

    Fulltext@MSK | Save
  • Preclinical development and first-in-human imaging of 89Zr-daratumumab for CD38 targeted imaging of myeloma
    Meeting Abstract

    Ulaner, G.; Sobol, N.; O'Donoghue, J.; Burnazi, E.; Staton, K.; Weber, W.; Lyashchenko, S.; Lewis, J.; Landgren, C. O.
    Journal of Nuclear Medicine (2019)

    Fulltext@MSK | Save
  • Antibody with infinite affinity for in vivo tracking of genetically engineered lymphocytes
    Journal Article

    Krebs, S.; Ahad, A.; Carter, L. M.; Eyquem, J.; Brand, C.; Bell, M.; Ponomarev, V.; Reiner, T.; Meares, C. F.; Gottschalk, S.; more...
    Journal of Nuclear Medicine (2018)

    Fulltext@MSK | Save
  • Phase I trial of alpha-particle immunotherapy with (225)Ac-lintuzumab and low-dose cytarabine in patients age 60 or older with untreated acute myeloid leukemia
    Meeting Abstract

    Jurcic, J.; Levy, M.; Park, J.; Ravandi, F.; Perl, A.; Pagel, J.; Smith, B.; Orozco, J.; Estey, E.; Kantarjian, H.; more...
    Journal of Nuclear Medicine (2017)

    Fulltext@MSK | Save
  • Remodeling the vascular microenvironment of glioblastoma with α-particles
    Journal Article

    Behling, K.; Maguire, W. F.; Di Gialleonardo, V.; Heeb, L. E. M.; Hassan, I. F.; Veach, D. R.; Keshari, K. R.; Gutin, P. H.; Scheinberg, D. A.; McDevitt, M. R.
    Journal of Nuclear Medicine (2016)

    Fulltext@MSK | Save
  • Vascular targeted radioimmunotherapy for the treatment of glioblastoma
    Journal Article

    Behling, K.; Maguire, W. F.; Puebla, J. C. L.; Sprinkle, S. R.; Ruggiero, A.; O'Donoghue, J.; Gutin, P. H.; Scheinberg, D. A.; McDevitt, M. R.
    Journal of Nuclear Medicine (2016)

    Fulltext@MSK | Save
  • Encapsulation of α-particle-emitting 225Ac3+ ions within carbon nanotubes
    Journal Article

    Matson, M. L.; Villa, C. H.; Ananta, J. S.; Law, J. J.; Scheinberg, D. A.; Wilson, L. J.
    Journal of Nuclear Medicine (2015)

    Fulltext@MSK | Save
  • Efficient 1-step radiolabeling of monoclonal antibodies to high specific activity with 225Ac for a-particle radioimmunotherapy of cancer
    Journal Article

    Maguire, W. F.; McDevitt, M. R.; Smith-Jones, P. M.; Scheinberg, D. A.
    Journal of Nuclear Medicine (2014)

    Fulltext@MSK | Save
  • Monitoring afatinib treatment in HER2-positive gastric cancer with (18)F-FDG and (89)Zr-trastuzumab PET
    Journal Article

    Janjigian, Y. Y.; Viola-Villegas, N.; Holland, J. P.; Divilov, V.; Carlin, S. D.; Gomes DaGama, E. M.; Chiosis, G.; Carbonetti, G.; de Stanchina, E.; Lewis, J. S.
    Journal of Nuclear Medicine (2013)

    Fulltext@MSK | Save
  • Imaging glutaminolysis in cancer
    Meeting Abstract

    Kung, H. F.; Ploessl, K.; Lieberman, B. P.; Wang, L.; Qu, W.; Lewis, J. S.; Dunphy, M.; Thompson, C. B.
    Journal of Nuclear Medicine (2013)

    Fulltext@MSK | Save